Nav: Home

Older donor lungs should be considered for transplantation

November 09, 2017

Chicago, Nov. 9, 2017 - With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

"The availability of suitable donor lungs for transplantation continues to be a major obstacle to increasing the number of lung transplants performed annually," said William Whited, MD, of the University of Louisville in Kentucky. "Research such as this that explores the means of expanding the donor pool is of critical importance."

Dr. Whited, along with senior author Matthew Fox, MD, and other colleagues from the University of Louisville queried the United Network of Organ Sharing (UNOS) thoracic transplant database to identify lung transplant recipients age 18 years or older. Between January 2005 and June 2014, 14,222 lung transplants were performed. Of these lung transplant recipients, 26% were age 50 years or younger, with 2% receiving lungs from donors older than age 60. Among this group of younger patients who received older donor lungs, there was no significant difference in 5-year survival when compared to patients who received lungs from younger donors.

The researchers also examined the impact of double versus single lung transplant on long-term survival, finding that younger patients who received older donor lungs experienced much better outcomes when a double versus a single transplantation was performed. The study showed that in younger patients who received a single lung transplant using organs from older vs. younger donors, there was a lower 5-year survival (15% vs. 50%). However, with a double lung transplant, there was no significant difference in 5-year survival (53% vs. 59%).

"This study demonstrated that reasonable outcomes are possible with the use of advanced age donors," said Dr. Whited.

"Ideal donor" criteria vary by hospital, but the researchers said that the criteria generally consist of brain death, age less than 45 to 50 years, minimal smoking history, and no evidence of pneumonia or trauma. Donor organs that do not meet all of the ideal donor criteria are sometimes accepted, but not always. Dr. Whited explained that while the use of extended criteria donor lungs varies from program to program, most surgeons should be willing to accept non-ideal donors, especially those who are older but otherwise good candidates.

"The vast majority of potential donors do not meet the relatively strict donor criteria," said Dr. Whited. "As a result, we need to continue exploring options that would expand the donor pool and more aggressively utilize extended criteria donors. Much like the general population, the donor pool has continued to grow older. Now more than ever, we have to rely on older donors."

The U.S. Organ Procurement & Transplant Network (OPTN) reports that 1,399 people currently are waiting for a lung transplant in the United States. The overall median waiting time for candidates on the wait list is 4 months, while more than 200 people die annually waiting for a lung transplant, according to an OPTN report.
-end-
Notes for editors

The article is "Does Donor Age and Double Versus Single Lung Transplantation Affect Survival of Young Recipients? ," by W.M. Whited, P. Henley, E.M. Schumer, J.R. Trivedi, V.H. van Berkel, and M.P. Fox. It appears in The Annals of Thoracic Surgery published by Elsevier.

Find comprehensive medical information presented for patients by leading experts in cardiothoracic surgery at the STS Patient Website.

Copies of this paper are available to credentialed journalists upon request; please contact Jennifer Bagley at +1 312-202-5865 or jbagley@sts.org.

About The Annals of Thoracic Surgery

The Annals of Thoracic Surgery is the official journal of The Society of Thoracic Surgeons (STS) and the Southern Thoracic Surgical Association. It has an impact factor of 3.700. Founded in 1964, STS is a not-for-profit organization representing more than 7,300 cardiothoracic surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society's mission is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.

About Elsevier

Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com

Media contact

Jennifer Bagley
Society of Thoracic Surgeons
1-312-202-5865
jbagley@sts.org

Elsevier

Related Lung Transplant Articles:

Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital stays
Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital readmissions and resulted in shorter hospital stays when patients were readmitted
New research finds signal of decreased early post transplant survival in new heart transplant system
In an analysis of the new heart organ allocation system for transplant patients in the US, researchers have identified a signal of a decrease in heart transplant survival rates.
Inhaled immunosuppressant may increase survival, pulmonary function after lung transplant
University of Maryland School of Medicine researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by inhaling a liposomal form of the immunosuppression drug cyclosporine through an investigational nebulizer.
Little-used drug combination may extend the lives of lung transplant patients
Median survival after lung transplant is less than six years.
Lung cell transplant boosts healing after the flu in mice
A serious case of the flu can cause lasting damage to the lungs.
Clinical trial shows promise for increasing lung transplant patients' life expectancy
A new study shows that a potential treatment for ischemia- reperfusion injury is safe for humans.
New clues discovered to lung transplant rejection
Researchers at Washington University School of Medicine in St. Louis have discovered clues to a particularly deadly form of rejection that can follow lung transplantation.
Blood test shows promise for early detection of severe lung-transplant rejection
Researchers have developed a simple blood test that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident.
Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Women are less likely to receive lung protective tidal volumes when being considered as a lung donor
A study presented at the CHEST Annual Meeting 2018 in San Antonio examined the adherence to lung protective ventilation and whether there were sex specific differences in mechanical ventilation strategies.
More Lung Transplant News and Lung Transplant Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Debbie Millman: Designing Our Lives
From prehistoric cave art to today's social media feeds, to design is to be human. This hour, designer Debbie Millman guides us through a world made and remade–and helps us design our own paths.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

Insomnia Line
Coronasomnia is a not-so-surprising side-effect of the global pandemic. More and more of us are having trouble falling asleep. We wanted to find a way to get inside that nighttime world, to see why people are awake and what they are thinking about. So what'd Radiolab decide to do?  Open up the phone lines and talk to you. We created an insomnia hotline and on this week's experimental episode, we stayed up all night, taking hundreds of calls, spilling secrets, and at long last, watching the sunrise peek through.   This episode was produced by Lulu Miller with Rachael Cusick, Tracie Hunte, Tobin Low, Sarah Qari, Molly Webster, Pat Walters, Shima Oliaee, and Jonny Moens. Want more Radiolab in your life? Sign up for our newsletter! We share our latest favorites: articles, tv shows, funny Youtube videos, chocolate chip cookie recipes, and more. Support Radiolab by becoming a member today at Radiolab.org/donate.